If anyone can attend, numbers are critical.
Join AACT's advocacy effort to have an overwhelming "grassroots" presence at the FDA public hearing to keep cell therapies in the practice of medicine.
This just in - http://www.patientsforstemcells.org/fda-public-hearing/ Excellent explanation and what you can do. Register even if you cannot attend in person.
FDA public hearing registration deadline is January 8th
Interventional Orthopedics Foundation (IOF) and AACT requests that you register for this critical meeting.
An important pending regulation curtailing the use of autologous cell therapy and biologics in the practice of medicine will be determined at a FDA sponsored final public hearing on April 13, 2016. The restrictive proposed regulations will prevent countless patients from receiving life-changing cell therapies.
It is not too late if you wish to have a voice . . .
Individuals who wish to attend or present at the FDA public hearing concerning four (4) draft guidances before they are accepted as final regulations must register by sending an email to CBERPublicEvents@fda.hhs.gov on or before January 8, 2016, and provide complete contact information, including name, title, affiliation, address, email and phone number.
Please register by email at
CBERPublicEvents@fda.hhs.gov
Here are more details. You can also submit a formal letter.
https://www.gpo.gov/fdsys/pkg/FR-2015-10-30/html/2015-27703.htm
Join AACT's advocacy effort to have an overwhelming "grassroots" presence at the FDA public hearing to keep cell therapies in the practice of medicine.
This just in - http://www.patientsforstemcells.org/fda-public-hearing/ Excellent explanation and what you can do. Register even if you cannot attend in person.
FDA public hearing registration deadline is January 8th
Interventional Orthopedics Foundation (IOF) and AACT requests that you register for this critical meeting.
An important pending regulation curtailing the use of autologous cell therapy and biologics in the practice of medicine will be determined at a FDA sponsored final public hearing on April 13, 2016. The restrictive proposed regulations will prevent countless patients from receiving life-changing cell therapies.
It is not too late if you wish to have a voice . . .
Individuals who wish to attend or present at the FDA public hearing concerning four (4) draft guidances before they are accepted as final regulations must register by sending an email to CBERPublicEvents@fda.hhs.gov on or before January 8, 2016, and provide complete contact information, including name, title, affiliation, address, email and phone number.
Please register by email at
CBERPublicEvents@fda.hhs.gov
Here are more details. You can also submit a formal letter.
https://www.gpo.gov/fdsys/pkg/FR-2015-10-30/html/2015-27703.htm